IN RECENT YEARS immunological methods have been applied to elucidating the structure and molecular biology of chromatin, and quantifying carcinogen adducts formed in DNA. Such studies have increased the limits of detection previously available and have opened up new avenues for the study of the distribution of adducts in chromatin and within cellular subpopulations. These achievements have accrued from the application of sensitive immunoassays, using polyclonal and now, with increasing importance, monoclonal antibodies. These methods were The reaction with carcinogens is not uniformly distributed along the DNA, aind nucleosomal-core proteins may influence the reactivity of N-acetoxy-AAF with internucleosomal DNA (Bases). Spacer proteins covalently bound to 3' and 5' ends of DNA are believed to form staggered protein discontinuities in DNA that are resistant to alkali and proteases (Werner). Antibodies that recognize these spacers also bind to filaments in the cytoplasm that are not composed of tubulin or actin. Evidence was presented that alkylation adducts may be more prevalent in regions close to the spacers. Reaction of AAF or chlorodiethyl triamine platinum-II chloride with G-C rich DNA-like polymers produces a transition from B-form DNA to Z-form DNA, whilst this power transition is prevented by binding cisdiammine dichloroplatinum II (cis-platin (Leng). Antibodies specific for Z-DNA were described, which bind to polytene chromosomes of Drosophila, then identifying the natural occurrence of Z-DNA, though whether this occurs in polytene bands or interbands in different species remains controversial.
The structure of chromatin has been probed using antibodies to DNA and chromosomal proteins. Micro-injection of affinity-purified antibodies against HMG and histone proteins into the cytoplasm and nucleus of cells, reveals the distribution of specific antigens and permits the investigation of their role in transcription (Bustin) and embryogenesis (Sommerville). Antibodies specific for different histones have been obtained by immunizing with synthetic hexapeptides of defined sequence (Van Regenmortel). Such probes reveal that the major antigenic sites of histones are at (H3), or close to (H4) the C-terminus, and that these sites are accessible in nucleosomes and core particles. Changes in immunofluorescence associated with two nuclear antigens that are expressed in GI and G2 but not in S cells were described (Turner). One antigen was expressed in metaphase chromosomes and the other was associated with the nuclear membrane. Transcription of polytene chromosomes is being investigated using monoclonal antibodies against chromosomal proteins (Bautz). One antibody appears specific for RNA polymerase II, whilst another selectivelv binds heatshock puffs 93D in D. melanoqaster and 48BC in D. hydei, evidently identifying an hn-RNP class that is stored in the nucleus. Other antibodies recognize proteins that may link hn-RNA to the nuclear matrix.
A major potential of antibodies is their use as histological stains in combination with a second, labelled antibody, to monitor the distribution and repair of adducts in cellular subpopulations of target tissues (Strickland, Zarebska) a method that may prove quantitative if combined with image intensification and analysis (Rajewsky, Bustin). However, the accessibility of DNA in situ to antibodies is affected by the degree of packing in the higher structures of chromatin or chromosomes (Nehls). Furthermore the accessibility of adducts in chromatin in situ is reflected by the kinetics of excision repair (Slor).
To date, most DNA adducts for which antibodies are available result from the reaction of monofunctional agents. Such antibodies could find immediate application in monitoring individual exposure to specific carcinogens (Legraverend). There is also considerable interest in the possibility of producing antibodies specific for DNA-DNA and DNA-protein cross-linkages which would be of value in monitoring therapy involving bifunctional agents. In some disease conditions it may be useful to measure cell-proliferative status with antinucleosidc antibodies which react strongly with cells in S (Bases) or with antibodies to chromatin proteins expressed in GJ and G2 (Turner). The ability to introduce nuclear antibodies into living cells by micro-injection (Bustin) or fusion with loaded erythrocyte ghosts (Slor) suggests a new means of inhibiting repair of specific lesions that may help establish their role in cytotoxicity, mutagenicitv-or cell transformation.
The Workshop has demonstrated that this relatively new field of application of immunological methods to investigate the structure and modification of chromatin has great potential in enabling otherwise impractical studies to be undertaken. As more and better defined antibodies become available it is expected that they will stimulate further ingenuity in elucidating the molecular architecture of chromatin and its modification by carcinogenic and therapeutic agents. W"e look forward to further exciting future developments. 
